Cat.#: BBM-3C-112
Description | 3D Hydrogel Kits (Pre-Configured), a pre-configured 3D hydrogel system, consists of RGD (arginyl glycyl aspartate) degradable polymer and CD cell degradable cross-linking agent. When RGD and CD cross-linkers are mixed, they cross-link into a gel. |
Unit | 1 kit |
Storage | −70°C |
Shipping | Dry ice |
Applications | Used for 3D-culture of various cell types, spheroids and tissue samples. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-084 | 3D CD-Link |
When the 3D CD-Link molecule, which is made up of a polyethylene glycol-peptide conjugate with thiol groups on both ends, is mixed with polymers Mal-PVA, Mal-Dextran, SG-PVA, and SG-Dextran, the thiol groups on CD-Link react with thiol-reactive groups on the polymers, forming stable thioether bonds, thus leading to the creation of the hydrogel.
|
inquiry |
BBM-3C-081 | 3D Dextran-HA Hydrogel Kit |
3D Dextran-HA Hydrogel Kit contains the necessary reagents for creating hydrogels containing hyaluronic acid, which are SG-Dextran and HyLink, a thiol-functionalized hyaluronic acid crosslinker. The formation of a gel through the stable bonding of thiol groups on HyLink with thiol-reactive groups on SG-Dextran, when the two reagents are combined at physiological pH (pH 7.2).
|
inquiry |
BBM-3C-116 | 3D Cell Culture Hydrogel Matrix Kit (RGD) |
3D Cell Culture Hydrogel Matrix Kit (RGD) is a high-concentration, adjustable, xeno-free (animal source-free) hydrogel system. This system was modified with the cell adhesion peptide RGD to promote cell attachment and cell-matrix interactions during 3D cell culture.
|
inquiry |
BBM-3C-083 | 3D PEG-Link |
3D PEG-Link molecule contains polyethylene glycol that has a thiol at each end. When it is mixed with polymers, such as Mal-PVA, Mal-Dextran, SG-PVA, and SG-Dextran, the thiol groups on PEG-Link create stable thioether bonds with thiol-reactive groups on the polymers, leading to the formation of the hydrogel.
|
inquiry |
BBM-3C-087 | 3D SG-PVA |
3D SG-PVA consists of polyvinyl alcohol functionalized with thiol-reactive groups (SG-PVA), which can be used together with other components PEG-Link or CD-Link to set up cell-compatible hydrogels.
|
inquiry |
BBM-3C-119 | 3D MSC Hydrogel Kit |
3D MSC Hydrogel Kit is a ready-to-use hydrogel system for the three-dimensional (3D) mesenchymal stem cells (MSC) culture. It is animal-free and can be used directly with cells for 3D culture or to generate hydrogel cell beads.
|
inquiry |
BBM-3C-108 | 3D Cell Culture Hydrogels Kit (Peptides) |
3D Cell Culture Hydrogels Kit (Peptides) is a synthetic peptide hydrogel free of animal origin, which can simulate the extracellular matrix of different tissues for 3D cell cultures.
|
inquiry |
BBM-3C-109 | ECM Gel from Engelbreth-Holm-Swarm Murine Sarcoma |
ECM Gel From Engelbreth-Holm-Swarm Murine Sarcoma is prepared from Engelbreth-Holm-Swarm sarcoma in mice for 3D cell culture.
|
inquiry |
BBM-3C-080 | 3D S-Life PVA-CD Hydrogel SG Kit |
3D PVA-CD Hydrogel Kit contains the necessary reagents for creating hydrogels that gel slowly and are compatible with living cells, which are polymeric SG-PVA and CD-Link, a cross-linking agent. The formation of a gel through the stable bonding of thiol groups on CD-Link with thiol-reactive groups on SG-PVA, when the two reagents are combined at physiological pH (pH 7.2).
|
inquiry |
BBM-3C-078 | 3D S-Dextran-CD Hydrogel Kit |
3D Dextran-CD Hydrogel Kit contains the necessary reagents for creating hydrogels that gel slowly and are compatible with living cells, which are SG-Dextran and CD-Link, a cross-linking agent. The formation of a gel through the stable bonding of thiol groups on CD-Link with thiol-reactive groups on SG-Dextran, when the two reagents are combined at physiological pH (pH 7.2).
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.